These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8479374)

  • 1. Cholestatic hepatitis associated with flucloxacillin.
    Derby LE; Jick H; Henry DA; Dean AD
    Med J Aust; 1993 May; 158(9):596-600. PubMed ID: 8479374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythromycin-associated cholestatic hepatitis.
    Derby LE; Jick H; Henry DA; Dean AD
    Med J Aust; 1993 May; 158(9):600-2. PubMed ID: 8479375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database.
    Russmann S; Kaye JA; Jick SS; Jick H
    Br J Clin Pharmacol; 2005 Jul; 60(1):76-82. PubMed ID: 15963097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flucloxacillin induced delayed cholestatic hepatitis.
    Miros M; Kerlin P; Walker N; Harris O
    Aust N Z J Med; 1990 Jun; 20(3):251-3. PubMed ID: 2372276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?
    Devereaux BM; Crawford DH; Purcell P; Powell LW; Roeser HP
    Eur J Clin Pharmacol; 1995; 49(1-2):81-5. PubMed ID: 8751026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flucloxacillin and cholestatic hepatitis.
    Jick H; Derby LE; Dean AD; Henry DA
    Med J Aust; 1994 Apr; 160(8):525. PubMed ID: 8170433
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study.
    Wing K; Bhaskaran K; Pealing L; Root A; Smeeth L; van Staa TP; Klungel OH; Reynolds RF; Douglas I
    J Antimicrob Chemother; 2017 Sep; 72(9):2636-2646. PubMed ID: 28859440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flucloxacillin-associated hepatic injury.
    Koek GH; Stricker BH; Blok AP; Schalm SW; Desmet VJ
    Liver; 1994 Oct; 14(5):225-9. PubMed ID: 7997079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver damage from flucloxacillin, cloxacillin and dicloxacillin.
    Olsson R; Wiholm BE; Sand C; Zettergren L; Hultcrantz R; Myrhed M
    J Hepatol; 1992 May; 15(1-2):154-61. PubMed ID: 1506634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitization.
    Victorino RM; Maria VA; Correia AP; de Moura C
    Arch Intern Med; 1987 May; 147(5):987-9. PubMed ID: 3579450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for development of flucloxacillin associated jaundice.
    Fairley CK; McNeil JJ; Desmond P; Smallwood R; Young H; Forbes A; Purcell P; Boyd I
    BMJ; 1993 Jan; 306(6872):233-5. PubMed ID: 8443520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis from 5-methoxypsoralen occurring in a patient with previous flucloxacillin hepatitis.
    Stephens RB; Cooper A
    Australas J Dermatol; 1999 Nov; 40(4):217-9. PubMed ID: 10570561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated study on risk of cholestatic liver disease and flucloxacillin.
    Li L; Jick H; Jick SS
    Br J Clin Pharmacol; 2009 Aug; 68(2):269-70. PubMed ID: 19694748
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-induced cholestatic hepatitis from common antibiotics.
    Med J Aust; 1992 Oct; 157(8):531. PubMed ID: 1479973
    [No Abstract]   [Full Text] [Related]  

  • 15. Flucloxacillin-induced liver injury.
    Andrews E; Daly AK
    Toxicology; 2008 Dec; 254(3):158-63. PubMed ID: 18793693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flucloxacillin-induced liver injury in elderly patient.
    Angheleanu R; Swart JN
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33958360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flucloxacillin induced liver disease: histopathological findings at biopsy and autopsy.
    Eckstein RP; Dowsett JF; Lunzer MR
    Pathology; 1993 Jul; 25(3):223-8. PubMed ID: 8265236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predisposing factors for flucloxacillin-related hepatotoxicity in children.
    Coombs S; Pittet LF; Tang K; Gwee A
    J Antimicrob Chemother; 2023 Nov; 78(11):2667-2671. PubMed ID: 37699070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Agranulocytosis and cholestatic hepatitis occurring during tetran therapy].
    Jakó J; Nagy P
    Orv Hetil; 1974 Apr; 115(17):995-6. PubMed ID: 4827222
    [No Abstract]   [Full Text] [Related]  

  • 20. Flucloxacillin hepatitis--an Australian epidemic.
    Desmond PV
    Aust N Z J Med; 1995 Jun; 25(3):195-6. PubMed ID: 7487684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.